Adjunctive Treatment for Decreasing Symptoms of Schizophrenia

Completed · Phase 2/Phase 3 · Has a placebo group

Conditions studied: Schizophrenia, Schizoaffective Disorder

In brief

This study will determine the effectiveness of treatment with glycine or d-cycloserine in addition to a normal antipsychotic regimen in improving negative symptoms and cognitive impairments in patients with schizophrenia.

Key facts

Study ID
NCT00222235
Run by
University of Maryland, Baltimore
People needed
240
Starts
2000-01-01
Expected to finish
2004-06-01
Last updated by the study team
2019-08-20

Who can join

Age: 18 and older, up to 54. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.